August 2022 Publications
- A century of attempts to develop an effective tuberculosis vaccine: Why they failed?. Soleimanpour S, Yaghoubi A, Sadat Seddighinia F, Rezaee SAR. Int Immunopharmacol. 2022 Aug. doi: 10.1016/j.intimp.2022.108791. Epub 2022 Apr 26.
- Effectiveness of Bacillus Calmette-Guérin vaccination against severe childhood tuberculosis in China: a case-based, multicenter retrospective study. Liao Q, Zheng Y, Wang Y, Ye L, Liu X, Jiao W, Liu Y, Zhu Y, Jia J, Sun L, Shen A, Wan C. Int J Infect Dis. 2022 Aug. doi: 10.1016/j.ijid.2022.04.023. Epub 2022 Apr 14.
- Intravenous BCG driven antigen recognition in a murine tuberculosis model. Singh S, Bolz M, Cornelius A, Desvignes L. Comp Immunol Microbiol Infect Dis. 2022 Aug. doi: 10.1016/j.cimid.2022.101838. Epub 2022 Jun 7.
- Reverse vaccinology approach to design a multi-epitope vaccine construct based on the Mycobacterium tuberculosis biomarker PE_PGRS17. Moodley A, Fatoba A, Okpeku M, Emmanuel Chiliza T, Blessing Cedric Simelane M, Pooe OJ. Immunol Res. 2022 Aug. doi: 10.1007/s12026-022-09284-x. Epub 2022 May 12.
- CWHM-12, an Antagonist of Integrin-Mediated Transforming Growth Factor-Beta Activation Confers Protection During Early Mycobacterium tuberculosis Infection in Mice. Scott NR, Thirunavukkarasu S, Rangel-Moreno J, Griggs DW, Khader SA. J Interferon Cytokine Res. 2022 Aug. doi: 10.1089/jir.2022.0027. Epub 2022 Aug 1.
- Disseminated BCG Infection in an Infant Masquerading as Langerhans Cell Histiocytosis. Rauf A, Ashok A, Sasidharan CK, J S. Indian J Pediatr. 2022 Aug. doi: 10.1007/s12098-022-04182-4. Epub 2022 Jun 2.
- T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis. Steigler P, Chhiba M, Francis V, Keyser A, Abrahams D, Hanekom W, Ntsekhe M, Scriba TJ. Vaccine X. 2022 Jun 14. doi: 10.1016/j.jvacx.2022.100177. eCollection 2022 Aug.
- Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination rates. Hacioglu A, Borekci S, Melikoglu M, Ozguler Y, Esatoglu SN, Ugurlu S, Seyahi E, Fresko I, Hamuryudan V, Ozdogan H, Yurdakul S, Hatemi I, Celik AF, Ongen HG, Hatemi G. Rheumatol Int. 2022 Aug. doi: 10.1007/s00296-021-04926-z. Epub 2021 Jul 6.
- BCG osteomyelitis: tips for diagnosis. Tsujioka Y, Nozaki T, Nishimura G, Miyazaki O, Jinzaki M, Kono T. Skeletal Radiol. 2022 Aug. doi: 10.1007/s00256-021-03966-7. Epub 2022 Jan 19.
- Transcriptomics for child and adolescent tuberculosis. Kaforou M, Broderick C, Vito O, Levin M, Scriba TJ, Seddon JA. Immunol Rev. 2022 Aug. doi: 10.1111/imr.13116. Epub 2022 Jul 12.
- Characterization of Mycobacterium tuberculosis-Specific Th22 Cells and the Effect of Tuberculosis Disease and HIV Coinfection. Makatsa MS, Omondi FMA, Bunjun R, Wilkinson RJ, Riou C, Burgers WA. J Immunol. 2022 Aug 1. doi: 10.4049/jimmunol.2200140. Epub 2022 Jul 1.
- Vaccine adjuvants to engage the cross-presentation pathway. Lee W, Suresh M. Front Immunol. 2022 Aug 1. doi: 10.3389/fimmu.2022.940047. eCollection 2022.
- Modelling infectious disease to support human health. Tobin DM. Dis Model Mech. 2022 Aug 1. doi: 10.1242/dmm.049824. Epub 2022 Aug 29.
- TOLLIP Optimizes Dendritic Cell Maturation to Lipopolysaccharide and Mycobacterium tuberculosis. Venkatasubramanian S, Pryor R, Plumlee C, Cohen SB, Simmons JD, Warr AJ, Graustein AD, Saha A, Hawn TR, Urdahl KB, Shah JA. J Immunol. 2022 Aug 1. doi: 10.4049/jimmunol.2200030. Epub 2022 Jul 8.
- Multi Epitope-Based Vaccine Design for Protection Against Mycobacterium tuberculosis and SARS-CoV-2 Coinfection. Pitaloka DAE, Izzati A, Amirah SR, Syakuran LA. Adv Appl Bioinform Chem. 2022 Aug 2. doi: 10.2147/AABC.S366431. eCollection 2022.
- Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives. Saied AA, Metwally AA, Dhawan M, Choudhary OP, Aiash H. EMBO Mol Med. 2022 Aug 8. doi: 10.15252/emmm.202216287. Epub 2022 Jun 27.
- Biomarkers to identify Mycobacterium tuberculosis infection among borderline QuantiFERON results. Uzorka JW, Bakker JA, van Meijgaarden KE, Leyten EMS, Delfos NM, Hetem DJ, Kerremans J, Zwarts M, Cozijn S, Ottenhoff THM, Joosten SA, Arend SM. Eur Respir J. 2022 Aug 10. doi: 10.1183/13993003.02665-2021. Print 2022 Aug.
- Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities. Díaz-Dinamarca DA, Salazar ML, Castillo BN, Manubens A, Vasquez AE, Salazar F, Becker MI. Pharmaceutics. 2022 Aug 11. doi: 10.3390/pharmaceutics14081671.
- Structure based design of effective HtpG-derived vaccine antigens against M. tuberculosis. Ruggiero A, Choi HG, Barra G, Squeglia F, Back YW, Kim HJ, Berisio R. Front Mol Biosci. 2022 Aug 11. doi: 10.3389/fmolb.2022.964645. eCollection 2022.
- Towards Reverse Vaccinology for Bovine TB: High Throughput Expression of Full Length Recombinant Mycobacterium bovis Proteins. Paliwal D, Thom M, Hussein A, Ravishankar D, Wilkes A, Charleston B, Jones IM. Front Mol Biosci. 2022 Aug 11. doi: 10.3389/fmolb.2022.889667. eCollection 2022.
- The impact of BCG strains and repeat vaccinations on immunodiagnostic tests in Eurasian badgers (Meles meles). Courcier EA, Collins SF, McCormick CM, Arnold ME, Corbett DM, Ford T, McGeown CF, Barry C, Kirke R, Menzies FD. Vaccine. 2022 Aug 12. doi: 10.1016/j.vaccine.2022.06.081. Epub 2022 Jul 9.
- Clinical presentation of bacille Calmette-Guérin (BCG) infections after BCG instillation therapy. Nurminen P, Ettala O, Uusitalo-Seppälä R, Högerman M, Kaipia A, Boström PJ. BJU Int. 2022 Aug 13. doi: 10.1111/bju.15870. Online ahead of print.
- Precision Vaccine Adjuvants for Older Adults: A Scoping Review. Nanishi E, Angelidou A, Rotman C, Dowling DJ, Levy O, Ozonoff A. Clin Infect Dis. 2022 Aug 15. doi: 10.1093/cid/ciac302.
- Ferrets as a model for tuberculosis transmission. Gupta T, Somanna N, Rowe T, LaGatta M, Helms S, Owino SO, Jelesijevic T, Harvey S, Jacobs W, Voss T, Sakamoto K, Day C, Whalen C, Karls R, He B, Tompkins SM, Bakre A, Ross T, Quinn FD. Front Cell Infect Microbiol. 2022 Aug 16. doi: 10.3389/fcimb.2022.873416. eCollection 2022.
- From rare disorders of immunity to common determinants of infection: Following the mechanistic thread. Casanova JL, Abel L. Cell. 2022 Aug 18. doi: 10.1016/j.cell.2022.07.004.
- Human Pulmonary Tuberculosis: Understanding the Immune Response in the Bronchoalveolar System. Herrera MT, Guzmán-Beltrán S, Bobadilla K, Santos-Mendoza T, Flores-Valdez MA, Gutiérrez-González LH, González Y. Biomolecules. 2022 Aug 20. doi: 10.3390/biom12081148.
- Genomic characteristics of two most widely used BCG vaccine strains: Danish 1331 and Pasteur 1173P2. Asadian M, Hassanzadeh SM, Safarchi A, Douraghi M. BMC Genomics. 2022 Aug 21. doi: 10.1186/s12864-022-08826-9.
- Efficacy of BCG Vaccination Against Respiratory Tract Infections in Older Adults During the Coronavirus Disease 2019 Pandemic. Moorlag SJCFM, Taks E, Ten Doesschate T, van der Vaart TW, Janssen AB, Müller L, Ostermann P, Dijkstra H, Lemmers H, Simonetti E, Mazur M, Schaal H, Ter Heine R, van de Veerdonk FL, Bleeker-Rovers CP, van Crevel R, Ten Oever J, de Jonge MI, Bonten MJ, van Werkhoven CH, Netea MG. Clin Infect Dis. 2022 Aug 24. doi: 10.1093/cid/ciac182.
- Modeling of MT. P495, an mRNA-based vaccine against the phosphate-binding protein PstS1 of Mycobacterium tuberculosis. Shahrear S, Islam ABMMK. Mol Divers. 2022 Aug 25. doi: 10.1007/s11030-022-10515-4. Online ahead of print.
- Persistent expression of activation markers on Mycobacterium tuberculosis-specific CD4 T cells in smear negative TB patients. Esmael A, Mihret A, Abebe T, Mussa D, Neway S, Ernst J, Rengarajan J, Wassie L, Howe R. PLoS One. 2022 Aug 30. doi: 10.1371/journal.pone.0271234. eCollection 2022.